日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research.

开发和表征三种新型FGFR抑制剂耐药宫颈癌细胞系,以推动宫颈癌研究

Bou Antoun Nauf, Afshan Mahmood Hiba-Tun-Noor, Walker Anthony J, Modjtahedi Helmout, Grose Richard P, Chioni Athina-Myrto

Advancements in Targeted Therapies for Colorectal Cancer: Overcoming Challenges and Exploring Future Directions

结直肠癌靶向治疗的进展:克服挑战,探索未来方向

Khelwatty, Said A; Puvanenthiran, Soozana; Seddon, Alan M; Bagwan, Izhar; Essapen, Sharadah; Modjtahedi, Helmout

The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis

HER家族成员、EGFRvIII、假定癌症干细胞生物标志物CD44和CD109在胶质母细胞瘤患者中的共表达和细胞定位及其对预后的影响

Mulliqi, Ermira; Khelwatty, Said; Bagwan, Izhar; Kamaludin, Ahmad; Morgan, Anna; Long, Natalie; Ashkan, Keyoumars; Modjtahedi, Helmout

Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma.

HER2/EGFRvIII/CD44 和 Claudin 18.2/CD109 共表达作为胃腺癌的新型预后指标

Al Janaby Tina, Khelwatty Said, Bagwan Izhar, Abbassi-Ghadi Nima, Modjtahedi Helmout

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

EGFRvIII 的表达及其与野生型 EGFR 的共表达,或推定的癌症干细胞生物标志物 CD44 或 EpCAM 与肝细胞癌患者的预后较差相关

Ozlem Sherif, Said A Khelwatty, Izhar Bagwan, Alan M Seddon, Angus Dalgleish, Satvinder Mudan, Helmout Modjtahedi

Synergistic Effects of Neratinib in Combination With Palbociclib or Miransertib in Brain Cancer Cells

Neratinib 与 Palbociclib 或 Miransertib 联合治疗脑癌细胞的协同作用

Ermira Mulliqi, Said Khelwatty, Anna Morgan, Keyoumars Ashkan, Helmout Modjtahedi

The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer Cells

阿法替尼与达沙替尼或 Miransertib 联合使用可协同抑制胃癌细胞生长

Tina Al-Janaby, Narmin Nahi, Alan Seddon, Izhar Bagwan, Said Khelwatty, Helmout Modjtahedi

Cytokine/Chemokine Release Patterns and Transcriptomic Profiles of LPS/IFNγ-Activated Human Macrophages Differentiated with Heat-Killed Mycobacterium obuense, M-CSF, or GM-CSF

LPS/IFNγ激活的人类巨噬细胞经热灭活的奥布氏分枝杆菌、M-CSF或GM-CSF分化后的细胞因子/趋化因子释放模式和转录组谱

Bazzi, Samer; El-Darzi, Emale; McDowell, Tina; Modjtahedi, Helmout; Mudan, Satvinder; Achkar, Marcel; Akle, Charles; Kadara, Humam; Bahr, Georges M

HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer

HER2表达可预测接受西妥昔单抗治疗的RAS野生型转移性结直肠癌患者的生存期

Khelwatty, Said A; Puvanenthiran, Soozana; Essapen, Sharadah; Bagwan, Izhar; Seddon, Alan M; Modjtahedi, Helmout

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients

酪氨酸磷酸酶受体γ对慢性粒细胞白血病患者酪氨酸激酶抑制剂治疗反应的预测价值

Mohamed A Ismail, Marzia Vezzalini, Hisham Morsi, Ahmad Abujaber, Ali Al Sayab, Kodappully Siveen, Mohamed A Yassin, Maria Monne, Muthanna Samara, Richard Cook, Claudio Sorio, Helmout Modjtahedi, Nader I Al-Dewik2